You just read:

Proteostasis Therapeutics Announces Broad New Dataset from Proprietary Combination and Add-On CFTR Modulator Studies in Cystic Fibrosis Patients

News provided by

Proteostasis Therapeutics, Inc.

Mar 25, 2019, 07:00 ET